JP-listed companies
Pharmarise Holdings Corporation

Pharmarise Holdings CorporationJP:2796

Market cap

¥7.9B

P/E ratio

22.8x

Income statement Balance sheet Cash flow

	May 31, 2013	May 31, 2014	May 31, 2015	May 31, 2016	May 31, 2017	May 31, 2018	May 31, 2019	May 31, 2020	May 31, 2021	May 31, 2022	May 31, 2023
Net sales	33,357	38,221	39,506	48,512	52,949	54,562	51,728	51,030	52,324	51,608	52,030
Cost of sales	28,415	32,208	33,130	41,582	45,731	46,612	44,386	43,592	44,256	43,491	43,896
Gross profit (loss)	4,942	6,013	6,376	6,930	7,218	7,950	7,342	7,437	8,067	8,117	8,134
Gross profit (loss)	4,942	6,013	6,376	6,930	7,218	7,950	7,342	7,437	8,067	8,117	8,134
Selling, general and administrative expenses	3,530	4,440	5,232	6,117	6,775	6,771	6,702	6,402	6,821	6,596	6,695
Selling, general and administrative expenses	3,530	4,440	5,232	6,117	6,775	6,771	6,702	6,402	6,821	6,596	6,695
Operating profit (loss)	1,412	1,573	1,143	813	442	1,179	640	1,034	1,246	1,520	1,438
Operating profit (loss)	1,412	1,573	1,143	813	442	1,179	640	1,034	1,246	1,520	1,438
Interest income	6	7	5	7	5	6	3	2	1	1	1
Dividend income	1	2	0	1	2	-	-	-	1	1	1
Commission income	-	-	-	28	-	-	-	-	-	14	24
Other	27	39	69	83	81	61	49	44	48	91	17
Rental income	15	21	18	15	18	22	19	21	23	17	16
Non-operating income	116	151	156	181	193	109	132	122	448	153	76
Subsidy income related to COVID-NOI	-	-	-	-	-	-	-	-	312	27	15
Other	27	39	69	83	81	61	49	44	48	91	17
Non-operating income	116	151	156	181	193	109	132	122	448	153	76
Interest income	6	7	5	7	5	6	3	2	1	1	1
Dividend income	1	2	0	1	2	-	-	-	1	1	1
Commission income	-	-	-	28	-	-	-	-	-	14	24
Other	27	39	69	83	81	61	49	44	48	91	17
Rental income	15	21	18	15	18	22	19	21	23	17	16
Non-operating income	116	151	156	181	193	109	132	122	448	153	76
Subsidy income related to COVID-NOI	-	-	-	-	-	-	-	-	312	27	15
Other	27	39	69	83	81	61	49	44	48	91	17
Non-operating income	116	151	156	181	193	109	132	122	448	153	76
Interest expenses	179	203	177	161	127	106	82	74	75	65	55
Rent cost	10	10	12	6	10	14	17	13	5	10	10
Commission expenses	12	65	32	14	7	1	33	-	20	31	8
Cost of the infection control under COVID19-NOE	-	-	-	-	-	-	-	-	280	21	-
Other	34	75	29	46	52	19	24	22	43	27	7
Other	34	75	29	46	52	19	24	22	43	27	7
Non-operating expenses	300	452	302	334	312	195	181	133	405	156	82
Non-operating expenses	300	452	302	334	312	195	181	133	405	156	82
Interest expenses	179	203	177	161	127	106	82	74	75	65	55
Rent cost	10	10	12	6	10	14	17	13	5	10	10
Commission expenses	12	65	32	14	7	1	33	-	20	31	8
Cost of the infection control under COVID19-NOE	-	-	-	-	-	-	-	-	280	21	-
Other	34	75	29	46	52	19	24	22	43	27	7
Other	34	75	29	46	52	19	24	22	43	27	7
Non-operating expenses	300	452	302	334	312	195	181	133	405	156	82
Non-operating expenses	300	452	302	334	312	195	181	133	405	156	82
Ordinary profit (loss)	1,228	1,272	998	660	324	1,092	590	1,023	1,288	1,517	1,431
Ordinary profit (loss)	1,228	1,272	998	660	324	1,092	590	1,023	1,288	1,517	1,431
Gain on sale of non-current assets	1	0	1	3	2	-	7	58	1	2	1
Extraordinary income	514	10	3	607	64	1	7	63	26	23	137
Reversal of provision for loss on store closings	-	-	-	-	-	-	-	5	-	21	16
Gain on bargain purchase	-	-	-	591	-	-	-	-	-	-	30
Subsidy income	28	-	-	-	-	-	-	-	-	-	88
Extraordinary income	514	10	3	607	64	1	7	63	26	23	137
Gain on sale of non-current assets	1	0	1	3	2	-	7	58	1	2	1
Extraordinary income	514	10	3	607	64	1	7	63	26	23	137
Reversal of provision for loss on store closings	-	-	-	-	-	-	-	5	-	21	16
Gain on bargain purchase	-	-	-	591	-	-	-	-	-	-	30
Subsidy income	28	-	-	-	-	-	-	-	-	-	88
Extraordinary income	514	10	3	607	64	1	7	63	26	23	137
Loss on retirement of non-current assets	6	43	3	21	20	2	4	-	-	18	59
Loss on sale of non-current assets	1	0	0	-	21	-	16	-	-	-	5
Loss on retirement of non-current assets	6	43	3	21	20	2	4	-	-	18	59
Impairment losses	24	46	54	150	336	625	134	114	51	200	244
Loss on tax purpose reduction entry of non-current assets	-	-	-	-	-	-	-	-	-	-	90
Loss on cancellation of rental contracts	27	37	-	15	-	-	-	-	-	-	119
Impairment losses	24	46	54	150	336	625	134	114	51	200	244
Extraordinary losses	111	127	58	242	387	679	197	267	112	218	518
Extraordinary losses	111	127	58	242	387	679	197	267	112	218	518
Loss on retirement of non-current assets	6	43	3	21	20	2	4	-	-	18	59
Loss on sale of non-current assets	1	0	0	-	21	-	16	-	-	-	5
Loss on retirement of non-current assets	6	43	3	21	20	2	4	-	-	18	59
Impairment losses	24	46	54	150	336	625	134	114	51	200	244
Loss on tax purpose reduction entry of non-current assets	-	-	-	-	-	-	-	-	-	-	90
Loss on cancellation of rental contracts	27	37	-	15	-	-	-	-	-	-	119
Impairment losses	24	46	54	150	336	625	134	114	51	200	244
Extraordinary losses	111	127	58	242	387	679	197	267	112	218	518
Extraordinary losses	111	127	58	242	387	679	197	267	112	218	518
Profit (loss) before income taxes	1,631	1,156	943	1,025	1	414	400	819	1,202	1,322	1,049
Profit (loss) before income taxes	1,631	1,156	943	1,025	1	414	400	819	1,202	1,322	1,049
Income taxes - current	672	866	662	533	453	609	391	469	764	816	749
Income taxes - current	672	866	662	533	453	609	391	469	764	816	749
Income taxes - deferred	-5	-87	53	123	-202	13	18	-231	18	47	-47
Income taxes - deferred	-5	-87	53	123	-202	13	18	-231	18	47	-47
Income taxes	667	779	715	655	251	622	410	238	782	864	702
Income taxes	667	779	715	655	251	622	410	238	782	864	702
Profit (loss)	-	-	229	369	-249	-208	-10	580	419	458	347
Profit (loss)	-	-	229	369	-249	-208	-10	580	419	458	347
Profit (loss) attributable to non-controlling interests	-	-	1	-12	-257	-179	-33	3	-6	10	14
Profit (loss) attributable to owners of parent	-	-	228	382	7	-28	23	577	426	447	333